Komori
Kabuki-Za (9661) · RiskRestated

Impact of the Spread of COVID-19 on Theater Performances and Individual Businesses

First written in FY2020. 7 of 14 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2026.

14entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2021 – FY2023-Q3MitigatedFY2023 – FY2024RestatedFY2025 – FY20262020: 320202021: 320212022: 320222023: 220232024: 120242025: 120252026: 12026
Same theme, other companies
Decline in event volume due to event restrictions and venue arrangement issuesA theme 35 companies write about · 37 as a headwind · 0 as a tailwind

Kabuki-Za moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.

The whole theme swung hardest in 2020: 24 of 28 companies on the "Worse" side.

11 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 35 companies compared. The sentences above are computed from all 35.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「The group continues to recognize the impact of infectious diseases, including COVID-19, as a business risk. A renewed deterioration in COVID-19 or the emergence of a new infectious disease may affect the group’s financial condition, operating results and cash flows.」

    The company reconfirmed the shift from disclosure of direct operating restrictions caused by infectious diseases to a focus on future risks if infections deteriorate again or a new infectious disease emerges.
  2. FY2025RestatedAnnual report

    「The group continues to recognize the impact of infectious diseases, including COVID-19, as a business risk. A renewed deterioration in COVID-19 or the emergence of a new infectious disease may affect the group’s financial condition, operating results and cash flows.」

    The disclosure has shifted from direct operating restrictions caused by infectious diseases to a focus on future risks if infections deteriorate again or a new infectious disease emerges.
  3. FY2024MitigatedAnnual report

    「During the consolidated fiscal year, the classification of COVID-19 under the Infectious Diseases Control Law was changed to a Class 5 infectious disease, restrictions on activities were lifted, and economic activity moved toward normalization.」

    Restrictions on activities related to COVID-19 were lifted and economic activity moved toward normalization. Meanwhile, the business risks section continues to describe the potential impact of a renewed deterioration in infections or a new infectious disease.
  4. FY2023MitigatedAnnual report

    「The group continues to recognize the impact of COVID-19 as a business risk. If the infection situation deteriorates again, it may affect the group’s financial condition, operating results and cash flows.」

    The infection risk continues to be recognized, but the disclosure has shifted to the potential impact if the situation deteriorates again, while also describing the partial easing of business restrictions, including the resumption of eating and drinking inside the venue.
  5. FY2023-Q3MaterialisedAnnual report

    「As restrictions on operations at related facilities were gradually eased, food and beverages became available in the auditorium seating areas and lobby from October. Revenue was ¥268.492 million, compared with ¥107.439 million in the same quarter of the previous year, while segment loss was ¥82.671 million, compared with a segment loss of ¥112.460 million in the same quarter of the previous year.」

    While infection-related restrictions on operations and limits on eating and drinking inside the venue affected operating results, sales and losses improved as restrictions on operations were eased and eating and drinking resumed.
  6. FY2023-Q2MaterialisedAnnual report

    「Against this backdrop, the Group continued infection-control measures, including restrictions on seating capacity in its restaurants and a ban on eating in the auditorium and lobby.」

    Restrictions on business activities due to infection continued to materialize as limits on seating capacity in the cafeteria and a ban on eating and drinking in the auditorium and lobby.
  7. FY2023-Q1MaterialisedAnnual report

    「Against this backdrop, the Group continued infection-control measures, including restrictions on seating capacity in its restaurants and a ban on eating in the auditorium and lobby.」

    Restrictions on business activities due to infection continued to materialize as limits on seating capacity in the cafeteria and a ban on eating and drinking in the auditorium and lobby.
  8. FY2022-Q3MaterialisedAnnual report

    「The Japanese economy remained in a difficult situation during the nine months ended the third quarter due to the impact of COVID-19. At the Kabukiza Theatre, performances continued with seating capacity restricted to half or less and thorough infection-control measures, including a ban on food and beverages in the auditorium and lobby. The cafeteria and restaurant and retail shop businesses of consolidated subsidiaries also operated under these restrictions.」

    The impact of COVID-19 continued and materialized in the form of limits on seating capacity, a ban on food and beverages, and operating restrictions on the cafeteria and restaurant and retail shop businesses.
  9. FY2022-Q1MaterialisedAnnual report

    「To prevent the spread of COVID-19, a second state of emergency was declared in January 2021 and lifted on 21 March, while a third state of emergency declared in April was extended through June. As a result, Kabuki performances and product exhibition events were canceled during the three months ended the first quarter. Although the state of emergency was lifted in June, limits on seating capacity and shortened operating hours continued to affect the group’s results.」

    The state of emergency resulted in the actual cancellation of Kabuki performances and product exhibition events, while limits on seating capacity and shortened operating hours continued to affect operating results.
  10. FY2021WorsenedAnnual report

    「The group recognizes the impact of COVID-19 as a major risk in conducting its business. With no prospect of the infection subsiding, it may have a material impact on the group’s financial condition and operating results.」

    The company explicitly identifies COVID-19 as a major business risk and states that, with no prospect of the infection subsiding, it may have a material impact on financial condition and operating results.
  11. FY2021-Q3Continued impact of infection and restrictions on business activitiesAnnual report

    「Kabuki performances at the Kabukiza Theatre, which had been canceled due to the impact of COVID-19, resumed in August. However, as a preventive measure against infection, food and beverages were prohibited in the auditorium and lobby, and performances were staged in four parts without intermissions (from January 2021, in three parts with short intermissions). These measures have significantly affected the performance of the cafeteria and restaurant and retail shop businesses operated inside the theater by a consolidated subsidiary. Restrictions on business activities to prevent infection may continue to have a material impact on the operating results of the group.」

    Following the resumption of performances, infection-control measures, including a ban on food and beverages, four-part performances and limits on attendance, have continued. The company states that these measures have affected the cafeteria and restaurant and retail shop businesses and that future restrictions on activities may have a significant impact.
  12. FY2021-Q2MaterialisedAnnual report

    「Due to the impact of COVID-19, Kabuki performances at the Kabukiza Theatre, which had been canceled through July, resumed in August. However, from the August through November performances, shows were staged in four parts without intermissions as a preventive measure against infection, significantly affecting the performance of the cafeteria and restaurant and retail shop businesses operated inside the theater by a consolidated subsidiary.」

    The cancellation of performances due to COVID-19, the four-part format after performances resumed and the impact on the cafeteria and restaurant and retail shop businesses have continued.
  13. FY2021-Q1MaterialisedAnnual report

    「Due to the impact of COVID-19, Kabuki performances at the Kabukiza Theatre are suspended through July and will resume in August. However, the August performances will be staged in four parts without intermissions as a preventive measure against infection, and this will have a significant impact on the performance of the cafeteria and restaurant and retail shop businesses operated inside the theater by a consolidated subsidiary. Restrictions on business activities to prevent the spread and transmission of infection may continue to have a material impact on the operating results of the group.」

    The cancellation of performances, the change to a four-part format and the impact on the cafeteria and restaurant and retail shop businesses resulting from COVID-19 have materialized, and the company also states that future restrictions on activities may have a significant impact.
  14. FY2020First statedAnnual report

    「The spread of the novel coronavirus has affected the Group's real estate leasing, cafeteria and food-service, and retail operations, including the postponement of the planned 3-month name-taking performances at the Kabukiza Theatre.」

    The company first separately disclosed as a significant subsequent event that the spread of COVID-19 had led to the postponement of scheduled performances and had affected its real estate leasing, cafeteria and restaurant, and retail shop businesses.
Moved together

"Dependence on Shochiku for Theater Operations and Risk of Performance Cancellations" moved the same way as this thread, in the same document, in 5 of its 14 moves.

542222★123456
  1. ★This thread
  2. 1Dependence on Shochiku for Theater Operations and Risk of Performance Cancellations5×
  3. 2Market Price Fluctuation Risk of Investment Securities4×
  4. 3Risk of Stagnant Personal Consumption and Economic Downturns in Emerging and Resource-Rich Economies2×
  5. 4Decline in Sales in the Cafeteria and Food Service Businesses2×
  6. 5Slight decline in sales and profit in the concession business2×
  7. 6Expanding Concession Stand Products, Sales Channels and Brands2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Kabuki-Za yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of the Spread of COVID-19 on Theater Performances and Individual Businesses | Kabuki-Za Co.,Ltd. (9661) | Komori